Valued at $25.1M at its later-stage round, Sep 2025. Nothing has traded since.
- ·Watch Angiocrine Bioscience: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Angiocrine Bioscience funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Seed Round | $2.1M | ▮ | ▮ |
| Oct 2021 | Later Stage VC | $58.1M | ▮ | ▮ |
Membership and data by Private Market View
Angiocrine Bioscience valuation
Angiocrine Bioscience was valued at $25.1 million at its later-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Angiocrine Bioscience raised?
Angiocrine Bioscience has raised $88.8 million in total; 2 of its rounds are on record. The largest on record was a $58.1 million later-stage round in Oct 2021; the most recent was a $2.1 million seed round in Aug 2025.
Angiocrine Bioscience has filed 2 Form Ds with the SEC since 2021, most recently in Sep 2025 ($2.1 million sold to 16 investors).
How Angiocrine Bioscience's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Angiocrine Bioscience, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Angiocrine Bioscience
- What is Angiocrine Bioscience worth?
- Angiocrine Bioscience is valued at $25.1M as of Oct 2026. Valued at $25.1M at its later-stage round, Sep 2025. Nothing has traded since.
- How much has Angiocrine Bioscience raised?
- Angiocrine Bioscience has raised $88.8M in total funding across 2 recorded rounds.
- When did Angiocrine Bioscience last raise?
- Angiocrine Bioscience last raised in Aug 2025 (Seed Round), raising $2.1M.